Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Influenza

  Free Subscription


27.09.2021

7 Ann Intern Med
4 Antimicrob Agents Chemother
1 Biochem Biophys Res Commun
5 BMC Pediatr
2 BMJ
2 Epidemiol Infect
12 J Clin Microbiol
1 J Exp Med
2 J Immunol
2 J Infect
11 J Infect Dis
5 J Virol
10 Lancet
7 MMWR Morb Mortal Wkly Rep
7 N Engl J Med
1 Pediatrics
2 PLoS Comput Biol
2 PLoS Med
68 PLoS One
3 Proc Natl Acad Sci U S A
23 Vaccine
7 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Intern Med

  1. QASEEM A, Yost J, Etxeandia-Ikobaltzeta I, Abraham GM, et al
    Update Alert: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2).
    Ann Intern Med. 2021 Jul 13. doi: 10.7326/L21-0389.
    PubMed        

  2. CHOPRA V
    When COVID-19 Strikes Your Hospital.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/M21-2681.
    PubMed        

  3. PATEL JJ
    A New Triple Threat.
    Ann Intern Med. 2021;174:1175-1176.
    PubMed        

  4. MAKI DG
    In suspected COVID-19, RT-PCR with nasal plus throat swabs has 97% sensitivity vs. nasopharyngeal swabs.
    Ann Intern Med. 2021 Sep 7. doi: 10.7326/ACPJ202109210.
    PubMed         Abstract available

  5. BANGASH AH
    The Proportion of SARS-CoV-2 Infections That Are Asymptomatic.
    Ann Intern Med. 2021;174:1344.
    PubMed        

  6. YANG F, Ma D
    The Proportion of SARS-CoV-2 Infections That Are Asymptomatic.
    Ann Intern Med. 2021;174:1343-1344.
    PubMed        

  7. ORAN DP, Topol EJ
    The Proportion of SARS-CoV-2 Infections That Are Asymptomatic.
    Ann Intern Med. 2021;174:1344-1345.
    PubMed        


    Antimicrob Agents Chemother

  8. SHAH S, Ackley TW, Topal JE
    Renal and Hepatic Toxicity Analysis of Remdesivir Formulations: Does What Is on the Inside Really Count?
    Antimicrob Agents Chemother. 2021;65:e0104521.
    PubMed         Abstract available

  9. HANSON BM, Dinh AQ, Tran TT, Arenas S, et al
    Candida auris Invasive Infections During a COVID-19 Case Surge.
    Antimicrob Agents Chemother. 2021 Aug 2:AAC0114621. doi: 10.1128/AAC.01146.
    PubMed         Abstract available

  10. SCHOOLEY RT, Carlin AF, Beadle JR, Valiaeva N, et al
    Rethinking Remdesivir: Synthesis, Antiviral Activity, and Pharmacokinetics of Oral Lipid Prodrugs.
    Antimicrob Agents Chemother. 2021;65:e0115521.
    PubMed         Abstract available

  11. YAN VC, Muller FL
    Why Remdesivir Failed: Preclinical Assumptions Overestimate the Clinical Efficacy of Remdesivir for COVID-19 and Ebola.
    Antimicrob Agents Chemother. 2021;65:e0111721.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  12. BARAL P, Bhattarai N, Hossen ML, Stebliankin V, et al
    Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion.
    Biochem Biophys Res Commun. 2021;574:14-19.
    PubMed         Abstract available


    BMC Pediatr

  13. YU L, Chen P, Zhu W, Sun J, et al
    Case Report:clinical experience of bilateral giant pediatric Testicular adrenal rest tumors with 3 Beta-Hydroxysteroid Dehydrogenase-2 family history.
    BMC Pediatr. 2021;21:405.
    PubMed         Abstract available

  14. HOWARD LM, Garguilo K, Gillon J, LeBlanc K, et al
    The first 1000 symptomatic pediatric SARS-CoV-2 infections in an integrated health care system: a prospective cohort study.
    BMC Pediatr. 2021;21:403.
    PubMed         Abstract available

  15. LAMBA V, Lien J, Desai J, Talati AJ, et al
    Management and short-term outcomes of neonates born to mothers with active perinatal SARS-CoV-2 infection.
    BMC Pediatr. 2021;21:400.
    PubMed         Abstract available

  16. BULLINGER LR, Boy A, Messner S, Self-Brown S, et al
    Pediatric emergency department visits due to child abuse and neglect following COVID-19 public health emergency declaration in the Southeastern United States.
    BMC Pediatr. 2021;21:401.
    PubMed         Abstract available

  17. WARSCHBURGER P, Petersen AC, von Rezori RE, Buchallik F, et al
    A prospective investigation of developmental trajectories of psychosocial adjustment in adolescents facing a chronic condition - study protocol of an observational, multi-center study.
    BMC Pediatr. 2021;21:404.
    PubMed         Abstract available


    BMJ

  18. DE BEER PAM, Van den Abbeele K
    Inviting adolescents aged 12-17 for covid-19 vaccination: the need for patience.
    BMJ. 2021;374:n2172.
    PubMed        

  19. HIPPISLEY-COX J, Coupland CA, Mehta N, Keogh RH, et al
    Risk prediction of covid-19 related death and hospital admission in adults after covid-19 vaccination: national prospective cohort study.
    BMJ. 2021;374:n2244.
    PubMed         Abstract available


    Epidemiol Infect

  20. SPINICCI M, Pengue L, Bartolozzi D, Quercioli M, et al
    Soccer in the time of COVID-19: 1 year report from an Italian top league club, March 2020-February 2021.
    Epidemiol Infect. 2021;149:e207.
    PubMed         Abstract available

  21. MUSA OAH, Chivese T, Bansal D, Abdulmajeed J, et al
    Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.
    Epidemiol Infect. 2021;149:e203.
    PubMed        


    J Clin Microbiol

  22. VALINETZ ED, Cangelosi GA
    A Look Inside: Oral Sampling for Detection of Non-oral Infectious Diseases.
    J Clin Microbiol. 2021;59:e0236020.
    PubMed         Abstract available

  23. WARD JD, Cornaby C, Schmitz JL
    Indeterminate QuantiFERON Gold Plus Results Reveal Deficient Interferon Gamma Responses in Severely Ill COVID-19 Patients.
    J Clin Microbiol. 2021;59:e0081121.
    PubMed         Abstract available

  24. THUDIUM RF, Stoico MP, Hogdall E, Hogh J, et al
    Early Laboratory Diagnosis of COVID-19 by Antigen Detection in Blood Samples of the SARS-CoV-2 Nucleocapsid Protein.
    J Clin Microbiol. 2021;59:e0100121.
    PubMed         Abstract available

  25. PEAPER DR, Rhoads DD, Sullivan KV, Couturier MR, et al
    Considerations from the College of American Pathologists for Implementation of an Assay for SARS-CoV-2 Testing after a Change in Regulatory Status.
    J Clin Microbiol. 2021;59:e0116721.
    PubMed         Abstract available

  26. SHOLUKH AM, Fiore-Gartland A, Ford ES, Miner MD, et al
    Evaluation of Cell-Based and Surrogate SARS-CoV-2 Neutralization Assays.
    J Clin Microbiol. 2021;59:e0052721.
    PubMed         Abstract available

  27. ALLAN-BLITZ LT, Klausner JD
    A Real-World Comparison of SARS-CoV-2 Rapid Antigen Testing versus PCR Testing in Florida.
    J Clin Microbiol. 2021;59:e0110721.
    PubMed         Abstract available

  28. SHIER KL
    Elevated Rates of Indeterminate Results on QuantiFERON-TB Gold Plus in COVID-19 Patients.
    J Clin Microbiol. 2021;59:e0141421.
    PubMed         Abstract available

  29. ARNAOUT RA
    Cooperation under Pressure: Lessons from the COVID-19 Swab Crisis.
    J Clin Microbiol. 2021;59:e0123921.
    PubMed         Abstract available

  30. BLACKALL D, Moreno R, Jin J, Plotinsky R, et al
    Performance Characteristics of the Roche Diagnostics cobas Liat PCR System as a COVID-19 Screening Tool for Hospital Admissions in a Regional Health Care Delivery System.
    J Clin Microbiol. 2021;59:e0127821.
    PubMed        

  31. JACOT D, Pillonel T, Greub G, Bertelli C, et al
    Assessment of SARS-CoV-2 Genome Sequencing: Quality Criteria and Low-Frequency Variants.
    J Clin Microbiol. 2021;59:e0094421.
    PubMed         Abstract available

  32. ZHANG SX, Balada-Llasat JM, Pancholi P, Sullivan KV, et al
    COVID-associated pulmonary aspergillosis in the US: is it rare or have we missed the diagnosis?
    J Clin Microbiol. 2021 Jul 21:JCM0113521. doi: 10.1128/JCM.01135.
    PubMed         Abstract available

  33. BANADA P, Green R, Banik S, Chopoorian A, et al
    A Simple Reverse Transcriptase PCR Melting-Temperature Assay To Rapidly Screen for Widely Circulating SARS-CoV-2 Variants.
    J Clin Microbiol. 2021;59:e0084521.
    PubMed         Abstract available


    J Exp Med

  34. MCCARTY NA
    Breathe-Your immune system is counting on it.
    J Exp Med. 2021;218.
    PubMed         Abstract available


    J Immunol

  35. YANG Q, Wen Y, Qi F, Gao X, et al
    Suppressive Monocytes Impair MAIT Cells Response via IL-10 in Patients with Severe COVID-19.
    J Immunol. 2021;207:1848-1856.
    PubMed         Abstract available


  36. Top Reads.
    J Immunol. 2021;207:1495.
    PubMed        


    J Infect

  37. CHANDRA S, Rawal R
    The surge in Covid related mucormycosis.
    J Infect. 2021;83:381-412.
    PubMed        

  38. LIANG J, Wang Z, Liu Y, Zeng L, et al
    Epidemiology and co-infection patterns in patients with respiratory tract infections in southern China between 2018 and 2020.
    J Infect. 2021;83:e6-e8.
    PubMed        


    J Infect Dis

  39. PATI A, Padhi S, Panda D, Suvankar S, et al
    A CD14 Polymorphism (C-159T rs2569190) Is Associated With SARS-CoV-2 Infection and Mortality in the European Population.
    J Infect Dis. 2021;224:921-922.
    PubMed        

  40. HEATON PM
    Herd Immunity: The Journey Is as Important as the Destination.
    J Infect Dis. 2021;224:931-933.
    PubMed        

  41. ERREN TC, Lewis P, Morfeld P
    Factoring in Coronavirus Disease 2019 Seasonality: Experiences From Germany.
    J Infect Dis. 2021;224:1096.
    PubMed        

  42. PADHI S, Sahu S, Pati A, Mohanty AK, et al
    Minor Allele of Intercellular Adhesion Molecule-1 Polymorphism (rs5498 1462A>G) Is Associated With SARS-CoV-2 Infection and Related Mortality.
    J Infect Dis. 2021;224:734-735.
    PubMed        

  43. CHOE PG, Kang CK, Kim KH, Yi J, et al
    Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection.
    J Infect Dis. 2021;224:1097-1099.
    PubMed        

  44. KRISTENSEN MK, Plovsing RR, Berg RMG, Krogh-Madsen R, et al
    Cell Adhesion Molecules and Vascular Endothelial Growth Factor at the Systemic and Alveolar Level in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.
    J Infect Dis. 2021;224:1101-1103.
    PubMed        

  45. TONG M, Zheng Q, Chen F, Zhu Y, et al
    Comment on: Cell Adhesion Molecules and Vascular Endothelial Growth Factor at the Systemic and Alveolar Level in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.
    J Infect Dis. 2021;224:1103-1104.
    PubMed        

  46. QI Y, Shaman J, Pei S
    Quantifying the impact of COVID-19 non-pharmaceutical interventions on influenza transmission in the United States.
    J Infect Dis. 2021 Sep 22. pii: 6374002. doi: 10.1093.
    PubMed         Abstract available

  47. XIAO J, de Mesquita JB, Leung NHL, Adenaiye O, et al
    Viral RNA and infectious influenza virus on mobile phones of influenza patients in Hong Kong and the United States.
    J Infect Dis. 2021 Sep 17. pii: 6371826. doi: 10.1093.
    PubMed         Abstract available

  48. GORSE GJ, Rattigan SM, Kirpich A, Simberkoff MS, et al
    Influence of Pre-Season Antibodies against Influenza Virus on Risk of Influenza Infection among Health Care Personnel.
    J Infect Dis. 2021 Sep 17. pii: 6371937. doi: 10.1093.
    PubMed         Abstract available

  49. BEVERLAND A, Keogan M, Connell J, De Gascun C, et al
    Longitudinal Serological Analysis Following a National Seroprevalence Study to Investigate COVID-19 Infection in People Living in Ireland.
    J Infect Dis. 2021;224:1100-1101.
    PubMed        


    J Virol

  50. SUN G, Sui Y, Zhou Y, Ya J, et al
    Structural basis of covalent inhibitory mechanism of TMPRSS2-related serine proteases by camostat.
    J Virol. 2021 Jun 23:JVI0086121. doi: 10.1128/JVI.00861.
    PubMed         Abstract available

  51. CHEN DY, Khan N, Close BJ, Goel RK, et al
    SARS-CoV-2 disrupts proximal elements in the JAK-STAT pathway.
    J Virol. 2021 Jul 14:JVI0086221. doi: 10.1128/JVI.00862.
    PubMed         Abstract available

  52. FERRARI M, Mekkaoui L, Ilca FT, Akbar Z, et al
    Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV-2 variants.
    J Virol. 2021 Jul 21:JVI0068521. doi: 10.1128/JVI.00685.
    PubMed         Abstract available

  53. LI Z, Gao F, Lan Y, Guan J, et al
    Porcine Haemagglutinating Encephalomyelitis Virus Triggers Neural Autophagy Independent of ULK1.
    J Virol. 2021 Jul 21:JVI0085121. doi: 10.1128/JVI.00851.
    PubMed         Abstract available

  54. PELZ L, Rudiger D, Dogra T, Alnaji FG, et al
    Semi-continuous propagation of influenza A virus and its defective interfering particles: analyzing the dynamic competition to select candidates for antiviral therapy.
    J Virol. 2021 Sep 22:JVI0117421. doi: 10.1128/JVI.01174.
    PubMed         Abstract available


    Lancet

  55. BEHAGUE D, Ortega F
    Mutual aid, pandemic politics, and global social medicine in Brazil.
    Lancet. 2021;398:575-576.
    PubMed        

  56. ROCHON PA, Kalia S, Higgs P
    Gendered ageism: addressing discrimination based on age and sex.
    Lancet. 2021;398:648-649.
    PubMed        

  57. ZUNIGA JM, Russell A, Lusimbo R, Tshabalala S, et al
    The costs of PEPFAR's leadership vacuum.
    Lancet. 2021;398:741.
    PubMed        

  58. COGHLAN R
    Broaden the narrative this World Humanitarian Day: honour those who comfort the dying.
    Lancet. 2021;398:659.
    PubMed        

  59. CARR EJ, Wu M, Harvey R, Wall EC, et al
    Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients.
    Lancet. 2021 Aug 12. pii: S0140-6736(21)01854.
    PubMed        

  60. READ JM, Green CA, Harrison EM, Docherty AB, et al
    Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave.
    Lancet. 2021 Aug 12. pii: S0140-6736(21)01786.
    PubMed        


  61. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019.
    Lancet. 2021 Aug 17. pii: S0140-6736(21)01207.
    PubMed         Abstract available

  62. BEHRENS GM, Cossmann A, Stankov MV, Nehlmeier I, et al
    SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination.
    Lancet. 2021 Aug 17. pii: S0140-6736(21)01891.
    PubMed        

  63. LANGLOIS EV, Dey T, Shah MG
    More than honour, humanitarian health-care workers need life-saving protection.
    Lancet. 2021;398:729-730.
    PubMed        

  64. MONTI M, Torbica A, Mossialos E, McKee M, et al
    A new strategy for health and sustainable development in the light of the COVID-19 pandemic.
    Lancet. 2021 Sep 9. pii: S0140-6736(21)01995.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  65. QUINT JJ, Van Dyke ME, Maeda H, Worthington JK, et al
    Disaggregating Data to Measure Racial Disparities in COVID-19 Outcomes and Guide Community Response - Hawaii, March 1, 2020-February 28, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1267-1273.
    PubMed         Abstract available

  66. LANGE SJ, Kompaniyets L, Freedman DS, Kraus EM, et al
    Longitudinal Trends in Body Mass Index Before and During the COVID-19 Pandemic Among Persons Aged 2-19 Years - United States, 2018-2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1278-1283.
    PubMed         Abstract available

  67. BAJEMA KL, Dahl RM, Prill MM, Meites E, et al
    Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalization - Five Veterans Affairs Medical Centers, United States, February 1-August 6, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1294-1299.
    PubMed         Abstract available

  68. GRANNIS SJ, Rowley EA, Ong TC, Stenehjem E, et al
    Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19-Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance - Nine States, June-August
    MMWR Morb Mortal Wkly Rep. 2021;70:1291-1293.
    PubMed         Abstract available

  69. YOMOGIDA K, Zhu S, Rubino F, Figueroa W, et al
    Post-Acute Sequelae of SARS-CoV-2 Infection Among Adults Aged >/=18 Years - Long Beach, California, April 1-December 10, 2020.
    MMWR Morb Mortal Wkly Rep. 2021;70:1274-1277.
    PubMed         Abstract available

  70. ROSENBERG ES, Holtgrave DR, Dorabawila V, Conroy M, et al
    New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1306-1311.
    PubMed         Abstract available

  71. SCOBIE HM, Johnson AG, Suthar AB, Severson R, et al
    Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status - 13 U.S. Jurisdictions, April 4-July 17, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1284-1290.
    PubMed         Abstract available


    N Engl J Med

  72. GORDON AC, Angus DC, Derde LPG
    Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply.
    N Engl J Med. 2021 Aug 18. pii: 10.1056/NEJMc2108482.
    PubMed        

  73. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Protecting against Severe Disease and Transmission.
    N Engl J Med. 2021;385:e44.
    PubMed        

  74. WERNER RM, Glied SA
    Covid-Induced Changes in Health Care Delivery - Can They Last?
    N Engl J Med. 2021;385:868-870.
    PubMed        

  75. BROWN MJ, Alazawi W, Kanoni S
    Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
    N Engl J Med. 2021 Aug 18. pii: 10.1056/NEJMc2108482.
    PubMed        

  76. HALL MA, Studdert DM
    "Vaccine Passport" Certification - Policy and Ethical Considerations.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2104289.
    PubMed        

  77. LEE GM
    The Importance of Context in Covid-19 Vaccine Safety.
    N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMe2112543.
    PubMed        

  78. ROSAS IO, Raby B, Tsai L
    Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply.
    N Engl J Med. 2021 Aug 18. pii: 10.1056/NEJMc2108482.
    PubMed        


    Pediatrics

  79. MEHTA K, Morris SK, Bettinger JA, Vaudry W, et al
    Antiviral Use in Canadian Children Hospitalized for Influenza.
    Pediatrics. 2021 Sep 21. pii: peds.2020-049672. doi: 10.1542/peds.2020-049672.
    PubMed         Abstract available


    PLoS Comput Biol

  80. YANG S, Senapati P, Wang D, Bauch CT, et al
    Targeted pandemic containment through identifying local contact network bottlenecks.
    PLoS Comput Biol. 2021;17:e1009351.
    PubMed         Abstract available

  81. BAUER S, Contreras S, Dehning J, Linden M, et al
    Relaxing restrictions at the pace of vaccination increases freedom and guards against further COVID-19 waves.
    PLoS Comput Biol. 2021;17:e1009288.
    PubMed         Abstract available


    PLoS Med

  82. MUTHUKUMAR AV, Morrell W, Bierer BE
    Evaluating the frequency of English language requirements in clinical trial eligibility criteria: A systematic analysis using ClinicalTrials.gov.
    PLoS Med. 2021;18:e1003758.
    PubMed         Abstract available

  83. KILMARX PH, Glass RI
    Building global health research capacity to address research imperatives following the COVID-19 pandemic.
    PLoS Med. 2021;18:e1003753.
    PubMed         Abstract available


    PLoS One

  84. PERAUD W, Quintard B, Constant A
    Factors associated with violence against women following the COVID-19 lockdown in France: Results from a prospective online survey.
    PLoS One. 2021;16:e0257193.
    PubMed         Abstract available

  85. KULKARNI R, Chen WC, Lee Y, Kao CF, et al
    Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters.
    PLoS One. 2021;16:e0257191.
    PubMed         Abstract available

  86. FALCO A, Girardi D, Dal Corso L, Yildirim M, et al
    The perceived risk of being infected at work: An application of the job demands-resources model to workplace safety during the COVID-19 outbreak.
    PLoS One. 2021;16:e0257197.
    PubMed         Abstract available

  87. MAHMUD S, Mohsin M, Khan IA, Mian AU, et al
    Knowledge, beliefs, attitudes and perceived risk about COVID-19 vaccine and determinants of COVID-19 vaccine acceptance in Bangladesh.
    PLoS One. 2021;16:e0257096.
    PubMed         Abstract available

  88. WISNEWSKI AV, Redlich CA, Liu J, Kamath K, et al
    Immunogenic amino acid motifs and linear epitopes of COVID-19 mRNA vaccines.
    PLoS One. 2021;16:e0252849.
    PubMed         Abstract available

  89. PEREZ-ARCE F, Angrisani M, Bennett D, Darling J, et al
    COVID-19 vaccines and mental distress.
    PLoS One. 2021;16:e0256406.
    PubMed         Abstract available

  90. PURBA FD, Kumalasari AD, Novianti LE, Kendhawati L, et al
    Marriage and quality of life during COVID-19 pandemic.
    PLoS One. 2021;16:e0256643.
    PubMed         Abstract available

  91. JONES P, Menon A, Hicken A, Rozek LS, et al
    Global adoption of personal and social mitigation behaviors during COVID-19: The role of trust & confidence.
    PLoS One. 2021;16:e0256159.
    PubMed         Abstract available

  92. LI K, Foutz NZ, Cai Y, Liang Y, et al
    Impacts of COVID-19 lockdowns and stimulus payments on low-income population's spending in the United States.
    PLoS One. 2021;16:e0256407.
    PubMed         Abstract available

  93. AKMAL MUHAMAT N, Hasan R, Saddki N, Mohd Arshad MR, et al
    Development and usability testing of mobile application on diet and oral health.
    PLoS One. 2021;16:e0257035.
    PubMed         Abstract available

  94. HA BTT, Ngoc Quang, Quoc Thanh P, Duc DM, et al
    Community engagement in the prevention and control of COVID-19: Insights from Vietnam.
    PLoS One. 2021;16:e0254432.
    PubMed         Abstract available

  95. SHIMUL SN, Alradie-Mohamed A, Kabir R, Al-Mohaimeed A, et al
    Effect of easing lockdown and restriction measures on COVID-19 epidemic projection: A case study of Saudi Arabia.
    PLoS One. 2021;16:e0256958.
    PubMed         Abstract available

  96. WANG Z, Zhang Z, Zhang Q, Gao J, et al
    COVID-19 and financial market response in China: Micro evidence and possible mechanisms.
    PLoS One. 2021;16:e0256879.
    PubMed         Abstract available

  97. MENA G, Blanco B, Casas I, Huertas A, et al
    Attitudes of Spanish hospital staff towards COVID-19 vaccination and vaccination rates.
    PLoS One. 2021;16:e0257002.
    PubMed         Abstract available

  98. RACHEV NR, Han H, Lacko D, Gelpi R, et al
    Replicating the Disease framing problem during the 2020 COVID-19 pandemic: A study of stress, worry, trust, and choice under risk.
    PLoS One. 2021;16:e0257151.
    PubMed         Abstract available

  99. BACCINI M, Cereda G
    Screening plans for SARS-CoV-2 based on sampling and rotation: An example in a European school setting.
    PLoS One. 2021;16:e0257099.
    PubMed         Abstract available

  100. COSTEIRA R, Lee KA, Murray B, Christiansen C, et al
    Estrogen and COVID-19 symptoms: Associations in women from the COVID Symptom Study.
    PLoS One. 2021;16:e0257051.
    PubMed         Abstract available

  101. AYEH SK, Abbey EJ, Khalifa BAA, Nudotor RD, et al
    Statins use and COVID-19 outcomes in hospitalized patients.
    PLoS One. 2021;16:e0256899.
    PubMed         Abstract available

  102. FINDYARTINI A, Greviana N, Hanum C, Husin JM, et al
    Supporting newly graduated medical doctors in managing COVID-19: An evaluation of a Massive Open Online Course in a limited-resource setting.
    PLoS One. 2021;16:e0257039.
    PubMed         Abstract available

  103. O'CONNOR RD, Barten DG, Latten GHP
    Preparations of Dutch emergency departments for the COVID-19 pandemic: A questionnaire-based study.
    PLoS One. 2021;16:e0256982.
    PubMed         Abstract available

  104. VILLOTEAU A, Asfar M, Otekpo M, Loison J, et al
    Elevated C-reactive protein in early COVID-19 predicts worse survival among hospitalized geriatric patients.
    PLoS One. 2021;16:e0256931.
    PubMed         Abstract available

  105. KAYAMBANKADZANJA RK, Schell CO, Mbingwani I, Mndolo SK, et al
    Unmet need of essential treatments for critical illness in Malawi.
    PLoS One. 2021;16:e0256361.
    PubMed         Abstract available

  106. SANTANA MF, Frank CHM, Almeida TVR, Jeronimo CMP, et al
    Hemorrhagic and thrombotic manifestations in the central nervous system in COVID-19: A large observational study in the Brazilian Amazon with a complete autopsy series.
    PLoS One. 2021;16:e0255950.
    PubMed         Abstract available

  107. STEPHENSON R, Walsh AR, Chavanduka TMD, Sallabank G, et al
    Widespread closure of HIV prevention and care services places youth at higher risk during the COVID-19 pandemic.
    PLoS One. 2021;16:e0249740.
    PubMed         Abstract available

  108. DERESSA W, Worku A, Abebe W, Getachew S, et al
    Social distancing and preventive practices of government employees in response to COVID-19 in Ethiopia.
    PLoS One. 2021;16:e0257112.
    PubMed         Abstract available

  109. SINGH I, Scarton C, Bontcheva K
    Multistage BiCross encoder for multilingual access to COVID-19 health information.
    PLoS One. 2021;16:e0256874.
    PubMed         Abstract available

  110. BARCELLINI L, Forlanini F, Sangiorgio A, Gambacorta G, et al
    Does school reopening affect SARS-CoV-2 seroprevalence among school-age children in Milan?
    PLoS One. 2021;16:e0257046.
    PubMed         Abstract available

  111. AUBRY M, Teiti I, Teissier A, Richard V, et al
    Self-collection and pooling of samples as resources-saving strategies for RT-PCR-based SARS-CoV-2 surveillance, the example of travelers in French Polynesia.
    PLoS One. 2021;16:e0256877.
    PubMed         Abstract available

  112. SHIONOYA Y, Taniguchi T, Kasai H, Sakuma N, et al
    Possibility of deterioration of respiratory status when steroids precede antiviral drugs in patients with COVID-19 pneumonia: A retrospective study.
    PLoS One. 2021;16:e0256977.
    PubMed         Abstract available

  113. BILLINGS J, Abou Seif N, Hegarty S, Ondruskova T, et al
    What support do frontline workers want? A qualitative study of health and social care workers' experiences and views of psychosocial support during the COVID-19 pandemic.
    PLoS One. 2021;16:e0256454.
    PubMed         Abstract available

  114. GRILL E, Eitze S, De Bock F, Dragano N, et al
    Sociodemographic characteristics determine download and use of a Corona contact tracing app in Germany-Results of the COSMO surveys.
    PLoS One. 2021;16:e0256660.
    PubMed         Abstract available

  115. VANDERWAAL K, Black L, Hodge J, Bedada A, et al
    Modeling transmission dynamics and effectiveness of worker screening programs for SARS-CoV-2 in pork processing plants.
    PLoS One. 2021;16:e0249143.
    PubMed         Abstract available

  116. TADESE M, Mihretie A
    Attitude, preparedness, and perceived self-efficacy in controlling COVID-19 pandemics and associated factors among university students during school reopening.
    PLoS One. 2021;16:e0255121.
    PubMed         Abstract available

  117. HENDELMAN T, Chaudhary A, LeClair AC, van Leuven K, et al
    Self-collection of capillary blood using Tasso-SST devices for Anti-SARS-CoV-2 IgG antibody testing.
    PLoS One. 2021;16:e0255841.
    PubMed         Abstract available

  118. BORREGO-MORELL JA, Huertas EJ, Torrado N
    On the effect of COVID-19 pandemic in the excess of human mortality. The case of Brazil and Spain.
    PLoS One. 2021;16:e0255909.
    PubMed         Abstract available

  119. BUSS GP, Wilson CM
    Exploring the cytotoxic mechanisms of Pediocin PA-1 towards HeLa and HT29 cells by comparison to known bacteriocins: Microcin E492, enterocin heterodimer and Divercin V41.
    PLoS One. 2021;16:e0251951.
    PubMed         Abstract available

  120. MALBERG J, Hadziosmanovic N, Smekal D
    Physiological respiratory parameters in pre-hospital patients with suspected COVID-19: A prospective cohort study.
    PLoS One. 2021;16:e0257018.
    PubMed         Abstract available

  121. SUNOHARA S, Asakura T, Kimura T, Ozawa S, et al
    Effective vaccine allocation strategies, balancing economy with infection control against COVID-19 in Japan.
    PLoS One. 2021;16:e0257107.
    PubMed         Abstract available

  122. EKSOMBATCHAI D, Wongsinin T, Phongnarudech T, Thammavaranucupt K, et al
    Pulmonary function and six-minute-walk test in patients after recovery from COVID-19: A prospective cohort study.
    PLoS One. 2021;16:e0257040.
    PubMed         Abstract available

  123. PIERACCI EG, Williams CE, Wallace RM, Kalapura CR, et al
    U.S. dog importations during the COVID-19 pandemic: Do we have an erupting problem?
    PLoS One. 2021;16:e0254287.
    PubMed         Abstract available

  124. ANDREOLA ML, Becquart F, Jomaa W, Verhoeven PO, et al
    The properties of hot household hygroscopic materials and their potential use for non-medical facemask decontamination.
    PLoS One. 2021;16:e0255148.
    PubMed         Abstract available

  125. LOVE J, Wimmer MT, Toth DJA, Chandran A, et al
    Comparison of antigen- and RT-PCR-based testing strategies for detection of SARS-CoV-2 in two high-exposure settings.
    PLoS One. 2021;16:e0253407.
    PubMed         Abstract available

  126. WALKER LJ, Codreanu TA, Armstrong PK, Goodwin S, et al
    SARS-CoV-2 infections among Australian passengers on the Diamond Princess cruise ship: A retrospective cohort study.
    PLoS One. 2021;16:e0255401.
    PubMed         Abstract available

  127. RATHNAYAKE S, Dasanayake D, Maithreepala SD, Ekanayake R, et al
    Nurses' perspectives of taking care of patients with Coronavirus disease 2019: A phenomenological study.
    PLoS One. 2021;16:e0257064.
    PubMed         Abstract available

  128. ARTHUR JM, Forrest JC, Boehme KW, Kennedy JL, et al
    Development of ACE2 autoantibodies after SARS-CoV-2 infection.
    PLoS One. 2021;16:e0257016.
    PubMed         Abstract available

  129. ANGELO AT, Alemayehu DS, Dachew AM
    Health care workers intention to accept COVID-19 vaccine and associated factors in southwestern Ethiopia, 2021.
    PLoS One. 2021;16:e0257109.
    PubMed         Abstract available

  130. AMES JL, Ferrara A, Avalos LA, Badon SE, et al
    COVID-19 prevalence, symptoms, and sociodemographic disparities in infection among insured pregnant women in Northern California.
    PLoS One. 2021;16:e0256891.
    PubMed         Abstract available

  131. LIU JJ, Dalton AN, Lee J
    The "Self" under COVID-19: Social role disruptions, self-authenticity and present-focused coping.
    PLoS One. 2021;16:e0256939.
    PubMed         Abstract available

  132. PAPADOPOULOU A, Musa H, Sivaganesan M, McCoy D, et al
    COVID-19 susceptibility variants associate with blood clots, thrombophlebitis and circulatory diseases.
    PLoS One. 2021;16:e0256988.
    PubMed         Abstract available

  133. MUNOZ-CULLA M, Roncancio-Clavijo A, Martinez B, Gorostidi-Aicua M, et al
    O group is a protective factor for COVID19 in Basque population.
    PLoS One. 2021;16:e0249494.
    PubMed         Abstract available

  134. AL MUTAIR A, Al Mutairi A, Alhumaid S, Maaz Abdullah S, et al
    Examining and investigating the impact of demographic characteristics and chronic diseases on mortality of COVID-19: Retrospective study.
    PLoS One. 2021;16:e0257131.
    PubMed         Abstract available

  135. VAHEY GM, McDonald E, Marshall K, Martin SW, et al
    Risk factors for hospitalization among persons with COVID-19-Colorado.
    PLoS One. 2021;16:e0256917.
    PubMed         Abstract available

  136. ADEYEMO OO, Tu S, Keene D
    How to lead health care workers during unprecedented crises: A qualitative study of the COVID-19 pandemic in Connecticut, USA.
    PLoS One. 2021;16:e0257423.
    PubMed         Abstract available

  137. VAN STRATEN B, Robertson PD, Oussoren H, Pereira Espindola S, et al
    Can sterilization of disposable face masks be an alternative for imported face masks? A nationwide field study including 19 sterilization departments and 471 imported brand types during COVID-19 shortages.
    PLoS One. 2021;16:e0257468.
    PubMed         Abstract available

  138. DE LA GUARDIA C, Rangel G, Villarreal A, Goodridge A, et al
    Development of in-house, indirect ELISAs for the detection of SARS-CoV-2 spike protein-associated serology in COVID-19 patients in Panama.
    PLoS One. 2021;16:e0257351.
    PubMed         Abstract available

  139. YUM HR, Park SH, Shin SY
    Influence of coronavirus disease 2019 on myopic progression in children treated with low-concentration atropine.
    PLoS One. 2021;16:e0257480.
    PubMed         Abstract available

  140. ZVIEDRITE N, Hodis JD, Jahan F, Gao H, et al
    COVID-19-associated school closures and related efforts to sustain education and subsidized meal programs, United States, February 18-June 30, 2020.
    PLoS One. 2021;16:e0248925.
    PubMed         Abstract available

  141. ASNAKEW S, Legas G, Muche Liyeh T, Belete A, et al
    Prevalence of post-traumatic stress disorder on health professionals in the era of COVID-19 pandemic, Northwest Ethiopia, 2020: A multi-centered cross-sectional study.
    PLoS One. 2021;16:e0255340.
    PubMed         Abstract available

  142. PAFUNDI PC, Galiero R, Simeon V, Rinaldi L, et al
    Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study.
    PLoS One. 2021;16:e0256903.
    PubMed         Abstract available

  143. BRYSON H, Mensah F, Price A, Gold L, et al
    Clinical, financial and social impacts of COVID-19 and their associations with mental health for mothers and children experiencing adversity in Australia.
    PLoS One. 2021;16:e0257357.
    PubMed         Abstract available

  144. DERUELLE P, Couffignal C, Sibiude J, Vivanti AJ, et al
    Prenatal care providers' perceptions of the SARS-Cov-2 vaccine for themselves and for pregnant women.
    PLoS One. 2021;16:e0256080.
    PubMed         Abstract available

  145. CARRIERI V, De Paola M, Gioia F
    The health-economy trade-off during the Covid-19 pandemic: Communication matters.
    PLoS One. 2021;16:e0256103.
    PubMed         Abstract available

  146. SAEED BQ, Elbarazi I, Barakat M, Adrees AO, et al
    COVID-19 health awareness among the United Arab Emirates population.
    PLoS One. 2021;16:e0255408.
    PubMed         Abstract available

  147. BAKEBILLAH M, Billah MA, Wubishet BL, Khan MN, et al
    Community's misconception about COVID-19 and its associated factors in Satkhira, Bangladesh: A cross-sectional study.
    PLoS One. 2021;16:e0257410.
    PubMed         Abstract available

  148. RUSSO G, Solimini A, Zuccala P, Zingaropoli MA, et al
    Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia: A retrospective cohort study.
    PLoS One. 2021;16:e0257376.
    PubMed         Abstract available

  149. MALFATTI G, Racano E, Delle Site R, Gios L, et al
    Enabling teleophthalmology during the COVID-19 pandemic in the Province of Trento, Italy: Design and implementation of a mHealth solution.
    PLoS One. 2021;16:e0257250.
    PubMed         Abstract available

  150. BAHAR MONI AS, Abdullah S, Bin Abdullah MFIL, Kabir MS, et al
    Psychological distress, fear and coping among Malaysians during the COVID-19 pandemic.
    PLoS One. 2021;16:e0257304.
    PubMed         Abstract available

  151. ENANE LA, Apondi E, Aluoch J, Bakoyannis G, et al
    Social, economic, and health effects of the COVID-19 pandemic on adolescents retained in or recently disengaged from HIV care in Kenya.
    PLoS One. 2021;16:e0257210.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  152. DALVIE NC, Rodriguez-Aponte SA, Hartwell BL, Tostanoski LH, et al
    Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  153. PROTO E, Zhang A
    COVID-19 and mental health of individuals with different personalities.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

  154. GOLDMAN E
    How the unvaccinated threaten the vaccinated for COVID-19: A Darwinian perspective.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed        


    Vaccine

  155. LI L, Honda-Okubo Y, Huang Y, Jang H, et al
    Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection.
    Vaccine. 2021;39:5940-5953.
    PubMed         Abstract available

  156. OKAMURA S, Ebina H
    Could live attenuated vaccines better control COVID-19?
    Vaccine. 2021 Aug 11. pii: S0264-410X(21)01038.
    PubMed         Abstract available

  157. TAYLOR SC, Hurst B, Martiszus I, Hausman MS, et al
    Semi-quantitative, high throughput analysis of SARS-CoV-2 neutralizing antibodies: Measuring the level and duration of immune response antibodies post infection/vaccination.
    Vaccine. 2021 Aug 6. pii: S0264-410X(21)01013.
    PubMed         Abstract available

  158. BROSH-NISSIMOV T, Sorek N, Yeshayahu M, Zherebovich I, et al
    Oropharyngeal shedding of herpesviruses before and after BNT162b2 mRNA vaccination against COVID-19.
    Vaccine. 2021 Aug 30. pii: S0264-410X(21)01148.
    PubMed         Abstract available

  159. DUDLEY MZ, Bernier R, Brewer J, Salmon DA, et al
    Walking the Tightrope: Reevaluating science communication in the era of COVID-19 vaccines.
    Vaccine. 2021 Aug 19. pii: S0264-410X(21)01070.
    PubMed         Abstract available

  160. LIU S, Liu J
    Public attitudes toward COVID-19 vaccines on English-language Twitter: A sentiment analysis.
    Vaccine. 2021 Aug 17. pii: S0264-410X(21)01106.
    PubMed         Abstract available

  161. KANJI JN, Bailey A, Fenton J, Ling SH, et al
    Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests.
    Vaccine. 2021 Aug 11. pii: S0264-410X(21)01042.
    PubMed         Abstract available

  162. BRAEYE T, Cornelissen L, Catteau L, Haarhuis F, et al
    Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021.
    Vaccine. 2021 Aug 19. pii: S0264-410X(21)01108.
    PubMed         Abstract available

  163. ROTENBERG S, Downer MB, Cooper J
    Making COVID-19 vaccinations accessible for people with disabilities.
    Vaccine. 2021 Aug 24. pii: S0264-410X(21)01110.
    PubMed        

  164. HAGAN LM, Dusseau C, Crockett M, Rodriguez T, et al
    COVID-19 vaccination in the Federal Bureau of Prisons, December 2020-April 2021.
    Vaccine. 2021 Aug 14. pii: S0264-410X(21)01078.
    PubMed         Abstract available

  165. TROGSTAD L, Robertson AH, Mjaaland S, Magnus P, et al
    Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: Large population-based cohort study.
    Vaccine. 2021 Aug 31. pii: S0264-410X(21)01103.
    PubMed         Abstract available

  166. LAW JLM, Logan M, Joyce MA, Landi A, et al
    SARS-COV-2 recombinant Receptor-Binding-Domain (RBD) induces neutralizing antibodies against variant strains of SARS-CoV-2 and SARS-CoV-1.
    Vaccine. 2021;39:5769-5779.
    PubMed         Abstract available

  167. BARRY M, Temsah MH, Aljamaan F, Saddik B, et al
    COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout.
    Vaccine. 2021 Sep 1. pii: S0264-410X(21)01131.
    PubMed         Abstract available

  168. LAIGLE V, Postma MJ, Pavlovic M, Cadeddu C, et al
    Vaccine market access pathways in the EU27 and the United Kingdom-analysis and recommendations for improvements.
    Vaccine. 2021 Aug 14. pii: S0264-410X(21)00918.
    PubMed         Abstract available

  169. MICHOS A, Tatsi EB, Filippatos F, Dellis C, et al
    Association of total and neutralizing SARS-CoV-2 spike -receptor binding domain antibodies with epidemiological and clinical characteristics after immunization with the 1(st) and 2(nd) doses of the BNT162b2 vaccine.
    Vaccine. 2021 Jul 24. pii: S0264-410X(21)00960.
    PubMed         Abstract available

  170. PHILLIPS A, Carlson S, Danchin M, Beard F, et al
    From program suspension to the pandemic: A qualitative examination of Australia's vaccine pharmacovigilance system over 10 years.
    Vaccine. 2021 Aug 7. pii: S0264-410X(21)00950.
    PubMed         Abstract available

  171. PARK SJ, Kang YM, Cho HK, Kim DY, et al
    Cross-protective efficacy of inactivated whole influenza vaccines against Korean Y280 and Y439 lineage H9N2 viruses in mice.
    Vaccine. 2021 Sep 20. pii: S0264-410X(21)01207.
    PubMed         Abstract available

  172. KIM DY, Kang YM, Cho HK, Park SJ, et al
    Development of a recombinant H9N2 influenza vaccine candidate against the Y280 lineage field virus and its protective efficacy.
    Vaccine. 2021 Sep 14. pii: S0264-410X(21)01149.
    PubMed         Abstract available

  173. VAN HOOSTE WLC
    Influenza vaccination at the workplace.
    Vaccine. 2021 Sep 14. pii: S0264-410X(21)01188.
    PubMed        

  174. BENJAMIN-CHUNG J, Arnold BF, Mishra K, Kennedy CJ, et al
    City-wide school-located influenza vaccination: A retrospective cohort study.
    Vaccine. 2021 Sep 14. pii: S0264-410X(21)01161.
    PubMed         Abstract available

  175. CIAPPONI A, Bardach A, Mazzoni A, Alconada T, et al
    Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review.
    Vaccine. 2021 Aug 13. pii: S0264-410X(21)01067.
    PubMed         Abstract available

  176. SELL H, Assi A, Driedger SM, Dube E, et al
    Continuity of routine immunization programs in Canada during the COVID-19 pandemic.
    Vaccine. 2021;39:5532-5537.
    PubMed         Abstract available

  177. SCHOCH-SPANA M, Brunson EK, Long R, Ruth A, et al
    The public's role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States.
    Vaccine. 2020 Oct 29. pii: S0264-410X(20)31368.
    PubMed         Abstract available


    Virus Res

  178. FORT H
    A very simple model to account for the rapid rise of the alpha variant of SARS-CoV-2 in several countries and the world.
    Virus Res. 2021;304:198531.
    PubMed         Abstract available

  179. ZHAO J, Wang L, Schank M, Dang X, et al
    SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.
    Virus Res. 2021;304:198508.
    PubMed         Abstract available

  180. HUANG X, Zhang F, Zhu K, Lin W, et al
    dsmCRISPR: Dual synthetic mismatches CRISPR/Cas12a-based detection of SARS-CoV-2 D614G mutation.
    Virus Res. 2021;304:198530.
    PubMed         Abstract available

  181. FRANCESCHI VB, Ferrareze PAG, Zimerman RA, Cybis GB, et al
    Mutation hotspots and spatiotemporal distribution of SARS-CoV-2 lineages in Brazil, February 2020-2021.
    Virus Res. 2021;304:198532.
    PubMed         Abstract available

  182. YE H, Bi Z, Fan W, Song S, et al
    Cellular hnRNPAB interacts with avian influenza viral protein PB2 and inhibits virus replication potentially by restricting PB2 mRNA nuclear export and PB2 protein level.
    Virus Res. 2021 Sep 20:198573. doi: 10.1016/j.virusres.2021.198573.
    PubMed         Abstract available

  183. YANG F, Xiao Y, Liu F, Yao H, et al
    Molecular Characterization and Antigenic analysis of reassortant H9N2 subtype avian influenza viruses in Eastern China in 2016.
    Virus Res. 2021 Sep 21:198577. doi: 10.1016/j.virusres.2021.198577.
    PubMed         Abstract available

  184. VALE FF, Vitor JMB, Marques AT, Azevedo-Pereira JM, et al
    Origin, phylogeny, variability and epitope conservation of SARS-CoV-2 worldwide.
    Virus Res. 2021;304:198526.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: